Study Stopped
Insufficient recruitment
A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy
1 other identifier
interventional
4
1 country
1
Brief Summary
Prostate cancer is the most common cancer and the second-leading cause of cancer death amongst men in the United States. Sonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness. It permits measurement of the elastic properties of tissue. These measurements can be transposed onto conventional anatomic ultrasound images, producing a colorized overlay that allows direct visualization of the anatomic distribution of tissue stiffness. In this study, we aim to determine whether prostate biopsies planned with sonoelastographic guidance would be more likely than random prostate biopsies to intersect with foci of carcinoma in the prostate gland, and to determine whether prostate biopsies planned with sonoelastographic guidance would be more likely than random prostate biopsies to yield histopathology representative of the final Gleason Score obtained at pathologic assessment of the resected prostate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable prostate-cancer
Started Dec 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 31, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Posted
Study publicly available on registry
December 13, 2012
CompletedResults Posted
Study results publicly available
May 20, 2014
CompletedOctober 20, 2017
October 1, 2017
3 years
October 31, 2012
April 17, 2014
October 19, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
The Number of Core Biopsies in These Targeted Regions
From elastography-prostatectomy pathology correlation, the following data will be obtained, 1) The number of planned core biopsies that would intersect foci of prostate carcinoma, 2) The Gleason Score that would be obtained, assuming that elastographically targeted biopsies sample the targeted region.
Participants will be followed until prostatectomy pathology is available (average 1 week)
Study Arms (1)
Sonoelastography
EXPERIMENTALSonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness.
Interventions
Sonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness.
Eligibility Criteria
You may qualify if:
- Age 18 years of age or older.
- Serum PSA between 4 and 10 ng/mL.
- A diagnosis of prostate cancer based on extended (twelve core) random prostate biopsy within three months prior to study entry.
- Clinically localized prostate carcinoma i.e. TNM stage T2c or less.
- The patient has elected to undergo radical prostatectomy to treat the prostate carcinoma.
- The patient consents to undergo a diagnostic transrectal ultrasound of the prostate with elastography.
You may not qualify if:
- \. Any contraindication to transrectal ultrasonography, including prior anorectal surgery, inflammatory bowel disease, rectal fistula, or fissure-in-ano.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Anthony E. Samir
- Organization
- Massachusetts General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Anthony E. Samir, MD
Massachusetts General Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Radiologist, Ultrasound Imaging Services Assistant Radiologist, Abdominal Imaging & Intervention
Study Record Dates
First Submitted
October 31, 2012
First Posted
December 13, 2012
Study Start
December 1, 2009
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
October 20, 2017
Results First Posted
May 20, 2014
Record last verified: 2017-10